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Spectral Unmixing-Based Reaction Monitoring of
Transformations between Nucleosides and Nucleobases**
Felix Kaspar,*[a, b] Robert T. Giessmann,[a] Sarah Westarp,[a, b] Katja F. Hellendahl,[a]
Niels Krausch,[a] Isabel Thiele,[a] Miriam C. Walczak,[a, b] Peter Neubauer,[a] and
Anke Wagner*[a, b]
The increased interest in (enzymatic) transformations between
nucleosides and nucleobases has demanded the development
of efficient analytical tools. In this report, we present an update
and extension of our recently described method for monitoring
these reactions by spectral unmixing. The presented method
uses differences in the UV absorption spectra of nucleosides
and nucleobases after alkaline quenching to derive their ratio
based on spectral shape by fitting normalized reference spectra.
It is applicable to a broad compound spectrum comprising
more than 35 examples, offers HPLC-like accuracy, ease of
handling and significant reductions in both cost and data
acquisition time compared to other methods. This contribution
details the principle of monitoring reactions by spectral
unmixing, gives recommendations regarding solutions to
common problems and applications that necessitate special
sample treatment. We provide software, workflows and refer-
ence spectra that facilitate the straightforward and versatile
application of the method.
Nucleoside-altering enzymes harbor significant potential for the
synthesis of nucleoside analogues. Nucleoside phosphorylases
(NPs), for instance, catalyze the reversible phosphorolytic
cleavage of nucleosides into the corresponding free nucleobase
and pentose-1-phosphate (Scheme 1) and are widely applied
for the preparation of modified nucleosides.[1–11] Consequently,
their kinetic and thermodynamic characterization has attracted
increased interest and demanded the development of efficient
analytical tools.[12,13]
Recently, we reported a UV/Vis spectroscopy-based method
for the monitoring of these reactions that largely eliminated the
need for HPLC.[14] For this method, we employed spectral
unmixing to derive nucleoside/nucleobase ratios from experi-
mental UV absorption spectra based on suitable reference
spectra. Implemented into the workflow of a high-throughput
assay, this methodology facilitated a >20-fold reduction of data
acquisition time and a roughly fivefold decrease in cost
compared to conventional HPLC, while maintaining very
comparable accuracy and excellent reproducibility. Unlike other
non-HPLC-based methods,[15–27] our approach offers a uniquely
broad substrate spectrum, including all natural and several
examples of modified nucleosides, as well as high adaptability
and the straightforward application to any substrate without
the need for laborious method development.
Following the initial report of our method, it has found
wide-spread use in our laboratory and was successfully applied
to several projects. Most notably, previous spectral character-
ization of a range of nucleoside substrates and their corre-
sponding nucleobases enabled the investigation of the thermo-
dynamic reaction control of nucleoside phosphorolysis.[12] Here
we were able to measure slight temperature-induced changes
of reaction equilibria of the phosphorolysis of 24 nucleosides
that allowed convenient experimental access to thermodynamic
properties of those reactions. Knowledge of the UV absorption
spectra of nucleosides and nucleobases also enabled qualitative
reaction monitoring of nucleoside transglycosylations to deter-
mine the time to equilibrium and reduce sampling effort.[11]
Further work to employ our method for the kinetic character-
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Scheme 1. Nucleoside/nucleotide phosphorolysis of pyrimidine or purine
species. With the exceptions of cytosine and 1,2,4-triazole-3-carboxamide, all
nucleobases featured in this report are described.
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ization of several NPs across their broad working space to probe
the limits of their tolerance to harsh reaction conditions is
currently underway.[28] In addition, this method has greatly
aided our efforts to explore the substrate spectra of other
nucleobase-cleaving enzymes,[29] empowered screening
projects[30] and overall alleviated our dependence on HPLC.[31]
Ultimately, these examples showcase the remarkable potential
of our spectral unmixing-based method for high sample
throughput and efficient monitoring of nucleobase cleavage
reactions.
In this update we expand the scope of established
substrates, share our experience and recommendations regard-
ing solutions to common problems and describe some
examples of alternative uses of the original method that
necessitate deviation from the previously reported protocol.
This contribution highlights the utility of spectral unmixing for
the monitoring and analysis of (enzymatic) nucleobase cleavage
reactions and will prove helpful to all current and future users
of our previously published method.[14]
The principle of reaction monitoring by spectral unmixing
Spectral unmixing in this case describes the concept of linear
combination of absorption spectra that can be traced back to
its individual components. In this sense, any mixture of two (or
more) compounds with known absorption spectra can be
deconvoluted into its constituents if appropriate reference
spectra are available.[32]
Our method for monitoring of nucleobase cleavage reac-
tions employs this concept by deriving nucleoside/nucleobase
ratios from experimental spectra recorded after alkaline dilution
of samples from a reaction mixture.[14] Under alkaline conditions
the UV absorption spectra of nucleosides and nucleobases
(Figure 1A) differ sufficiently to allow discrimination (Fig-
ure 1B).[33–35] Therefore, previously recorded reference spectra
can be fitted to a background-corrected experimental spectrum
(Figure 1C) to determine the contribution and ratio of its
individual constituents (namely substrate and product of the
reaction). This approach allows for efficient reaction monitoring
when multiple UV absorption spectra from a given reaction are
available and can be deconvoluted into their individual
components to derive the respective degree of conversion
(Figure 1D). Conveniently, nearly all nucleoside-nucleobase pairs
display an isosbestic point of base cleavage that allows for
normalization to correct for differences in signal intensity which
in turn eliminates potential errors from pipetting inaccuracy. At
the isosbestic point, the nucleoside and nucleobase in question
possess the same extinction coefficient which manifests itself as
a constant signal intensity at this wavelength throughout a
reaction (see Figure 1D for the pair of 1 and 3).
In this workflow, alkaline dilution of the sample serves a
threefold purpose. This step simultaneously terminates the
reaction by denaturing the enzyme, adjusts the concentration
of the analytes and regulates the pH value of the sample to
achieve deprotonation and spectral shifting of the UV absorp-
tion spectra. The suitable degree of alkaline dilution as well as
the concentration of the base used for dilution (in our case
aqueous NaOH) varies between different nucleoside-nucleobase
pairs, since the extinction coefficients and the pH range for
stable and reproducible spectra needed for analysis differ. For
example, purine nucleosides generally display a stronger UV
absorption than pyrimidine nucleosides, which requires smaller
sampling volumes to achieve the same peak signal intensity for
these substrates.
Although we mainly discuss nucleobase cleavage (e.g., by
nucleoside phosphorolysis) in this report, spectral unmixing-
based reaction monitoring can also be applied to observe the
reverse reaction. The same principles, strategies and challenges
considered below for phosphorolysis reactions also pertain to
the corresponding transformations in the glycosylation direc-
tion.
Updated list of established substrates
Extending our previously reported list of 20 nucleosides,[14] we
herein present the spectral characteristics of 38 substrates
(Table 1). Reference spectra for all compounds and their bases
listed in Table 1 are freely available from the externally hosted
supplementary material.[36] The updated list of established
substrates now includes several modified purine nucleosides
(22–27 and 33–36) and highly modified pyrimidines such as 5-
trifluoromethyluridine (15). Notably, we also characterized some
5’-phosphorlyated nucleotides and found their spectral proper-
ties to be essentially identical to their respective non-
phosphorylated counterparts, conveniently allowing the reac-
tion monitoring for these substrates without the need for
additional reference spectra or method development.
Dealing with background
The most common obstacle with the presented method is
background absorption. Different types of background absorp-
tion are typically observed and need to be addressed individu-
ally (Figure 2). Please note that while we use the phosphorolysis
of thymidine (1, Figure 2A) as an example reaction in this
manuscript, the same principles translate to all nucleosides and
nucleotides and can be applied in the same manner.
An occasional and unavoidable type of background signal is
atypical UV absorption of the multiwell plate or of particles. A
typical background signal is in the range of 0.03 absorption
units (AU) at 300 nm and curves up towards slightly higher
intensities at 250 nm (Figure 2B). This background is very well
reproducible and easily adjusted for, as described in our original
method. However, on average in approximately 1–2% of all
measurements, we observed increased absorption across the
entire spectrum apparent as a distinct baseline shift (Figure 2C).
This results in an inability to obtain accurate fits without manual
spectral processing (which we choose to explicitly abstain
from), as in these cases the baseline can be shifted >0.10 AU.
The straightforward solution in this case is remeasurement of
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the sample in a different well, which generally resolves the
problem.
We did not mention correction for protein background in
our initial report. That is because in most cases enzyme
background absorption in the considered range of 250–350 nm
is quasi indetectable when using protein concentrations of
50 μg/mL or less in the reaction mixture that is sampled. In
selected instances where either higher concentrations and/or
especially UV-active enzymes are used, appropriate background
correction of the experimental sample may be necessary
(Figure 2D). This can easily be carried out with a spectrum of a
suitably diluted sample of the enzyme. Note that one may keep
using the previously obtained reference spectra for the
Figure 1. The principle of spectral unmixing-based reaction monitoring. A) Enzymatic phosphorolysis of thymidine (1) into 2-deoxyribose-1-phosphate (2) and
the free nucleobase 3 as well as deprotonation after alkaline quenching. Representative resonance structures are shown. B) The substrate 1 and product 3 of
the reaction have markedly different UV absorption spectra under alkaline conditions. C) The spectra of 1 (blue) and 3 (red) can be fitted to an experimental
spectrum (black line) obtained during a reaction to derive the individual contributions of both species to the observed spectrum (hashed areas). D) Unmixing
of multiple experimental spectra obtained during a reaction (left) enables reaction monitoring by deriving the degree of conversion at every sampled
timepoint (right). Spectral unmixing of nucleoside transformations generally includes background correction, normalization to the isosbestic point of base
cleavage, and fitting of the respective reference spectra. The spectra and conversions presented in this figure serve an illustrative purpose and were generated
from the reference spectra of 1 and 3, as described in the externally hosted Supporting Information.[36] Typical reaction conditions include a nucleoside
concentration of 2 mM, 10 mM phosphate, 50 mM buffer of choice and 10 μg·mL  1 NP in a total volume of 500 μL.[12]
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substrate and product without any further alterations as those
are already corrected for their respective background.
Background absorption by UV-active components in the
reaction mixture needs to be addressed on a case-to-case basis.
Generally, all common buffers, protein stabilizing agents or
even artifacts from protein purification such as imidazole do
not represent any challenge to the method and allow
straightforward use of the standard procedure without any
additional background correction. When using some organic
cosolvents, however, we noticed significant background ab-
sorption in the lower wavelength region. Whereas alcohols
including methanol, ethanol, isopropanol, ethylene glycol and
glycerol may be used without alterations to the method (see
Supporting Information for details), solvents like dimethyl
sulfoxide (DMSO) and dimethyl formamide (DMF) create back-
ground signals that need to be accounted for (Figure 2E). In
these cases we found success employing background spectra
that reflect the specific content of UV-active solvent in the
sample and, if appropriate, limiting the wavelength range for
fitting of pyrimidine UV absorption spectra to the information-
rich tail region (i. e., 265–295 nm for uridine, 4). We even found
success when using especially UV-active reaction components,
such as dithiothreitol (DTT), that proved problematic in some
instances, by selecting appropriate substrates and selectively
limiting the fitting range (see the Supporting Information for
details and Figure S3 for an example).
In rare cases, we observed elevated baselines when using
very concentrated buffers for dilution and spectral measure-
ment. Again, appropriate background spectra to correct for this
shift succeeded in resolving this issue.
Nonetheless, it should be stressed that background correc-
tion does not always lead to accurate and reliable data. We
Table 1. Spectral properties of nucleosides, nucleotides, and their bases under alkaline conditions.
Compound[a] pH[b] λmax nucleoside/nucleo-
tide [nm]
λmax nucleobase
[nm]
Isosbestic point of base
cleavage [nm]
Spectral extension
[nm]
Pyrimidines uridine (4)[c] 13 262 281 271 310
2’-deoxyuridine (5)[c] 13 262 281 272 310
5-methyluridine (6)[c] 13 267 290 277 320
thymidine (1)[c] 13 266 290 278 320
5-fluorouridine (7)[c] 13.3 269 281 282 325
2’-deoxy-5-fluorouridine (8)[c] 13.3 268 281 280 325
5-bromouridine (9)[c] 13 276 290 283 330
5-bromo-2’-deoxyuridine (10)[c] 13 275 290 282 330
5-iodouridine (11)[c] 13.3 281 291 283 340
2’-deoxy-5-iodouridine (12)[c] 13.3 279 291 282 340
5-ethynyluridine (13)[c] 13.3 285 298 262, 288 340
2’-deoxy-5-ethynyluridine (14)[c] 13.3 284 298 262, 288 340
5-trifluoromethyluridine (15) 10 259 279 267 310
cytidine (16)[c] 13.7 271 281 271 310
2’-deoxycytidine (17)[c] 13.7 271 281 271 310
uridine-5’-monophosphate (18) 13 262 281 271 310
cytidine-5’-monophosphate (19) 13.7 271 281 271 310
Purines adenosine (20)[c] 13 259 268 267 310
2’-deoxyadenosine (21)[c] 13 259 268 267 310
2-fluoroadenosine (22) 13 260 268 271 310
2’-deoxy-2-fluoroadenosine (23) 13 260 268 271 310
2-chloroadenosine (24) 13 264 271 271 310
2-chloro-2’-deoxyadenosine (25) 13 264 271 271 310
2-aminoadenosine (26) 13 279 284 285 320
2-amino-2’-deoxyadenosine (27) 13 279 284 285 320
guanosine (28)[c] 13 264 273 279 310
2’-deoxyguanosine (29)[c] 13 264 273 279 310
inosine (30)[c] 13 252 262 263 320
2’-deoxyinosine (31)[c] 13 252 262 263 320
xanthosine (32) 13.3 276 282 276 320
2,6-dichloropurine riboside (33) 9 274 279 278 310
2,6-dichloro 2’-deoxyriboside (34) 9 274 279 278 310
6-chloro-2-fluoropurine riboside
(35)
9 269 273 271 310
6-chloro-2-fluoropurine 2’-deoxyri-
boside (36)
9 269 273 271 310
adenosine-5’-monophosphate (37) 13 259 268 267 310
guanosine-5’-monophosphate (38) 13 264 273 279 310
inosine-5’-monophosphate (39) 13 252 262 263 320
1,2,4-triazole-3-carboxamide ribo-
side (40)[d]
13 –[e] –[e] –[e] –[e]
[a] See Figure S1 for the structures of all compounds. [b] pH 9 was generally achieved in 50 mM Tris/NaOH buffer, pH 10 in 100 mM glycine/NaOH buffer,
pH 13 in 100 mM NaOH, pH 13.3 in 200 mM NaOH and pH 13.7 in 500 mM NaOH. [c] From the original report.[14] [d] Ribavirin. [e] Both λmax values are at
<250 nm, and there is no isosbestic point of base cleavage. Note that reaction monitoring can still be performed by single- or multi-wavelength detection,
but normalization to the isosbestic point of base cleavage is not possible for this substrate.
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experienced serious difficulties to correct for noise in instances
where the background signal intensity is comparable to the
signal intensity of the nucleoside-nucleobase pair under
investigation and directly and/or completely overlaps with this
signal (i. e., when examining the effect of enzyme inhibitors in
stoichiometric quantities). In principle, background subtraction
from the experimental spectrum is still possible and yields a
processed spectrum that can be fitted, but fit quality and,
consequently, accuracy of this approach suffered tremendously.
We ascribed this to the fact that the signal intensity of the
dynamic analytes (substrate and product) is largely irrelevant as
those values are normalized to the isosbestic point and
considered only in relation to one another, but background
signals from most sources are absolute quantities and thus vary
with and are very sensitive to pipetting accuracy. As a rule of
thumb, we recommend our method for cases where back-
ground absorption does not exceed 20% of the relevant signals
(i. e., signal-to-noise ratio should remain >5).
Reactant Instability
A critical factor for any method is stability and detectability of
the analytes. While all nucleosides and nucleobases in our
original report displayed excellent stability towards the quench-
ing and analysis conditions, we noted some issues within the
extended substrate range. Fluorinated purine nucleosides 22
and 23 were found to be quite sensitive to alkaline conditions
as these nucleosides underwent a temperature- and base-
promoted side reaction (Figure S2), presumably by 5’  OH attack
at the purine ring. We were able to bypass this issue by quick
sample processing avoiding any unnecessary storage. At room
Figure 2. Common background signals. A) Examplary UV-active reactants 1 and 3. B) Standard background observed from the absorption of the 96-well plate
filled with water or aqueous NaOH. Signals for 1 and 3 represent typical signal intensities observed for reactions with 2 mM nucleoside substrate and a
dilution factor of 15 during sampling. C) Baseline shift observed in approximately 1–2% of measurements. D) Background observed in reactions with
significant protein content. Purified Escherichia coli thymidine phosphorylase was used to recreate typical protein backgrounds by 15-fold dilution in 100 mM
NaOH. Note that some proteins can cause significantly more or less background. E) Representative background observed with some organic solvents. DMF
was diluted tenfold in 100 mM NaOH to record the background signals.
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temperature and pH 13, compounds 22 and 23 remained stable
enough for analysis for at least 10 min.
Further applications of the method
While the original protocol has proven to be a robust and
versatile method, we have used spectral unmixing-based
reaction monitoring in instances that deviated from the original
conditions. Some applications that necessitated adjusted
sample treatment are worth mentioning.
In our earlier report we have used purified protein in all
reactions.[14] The subsequently published applications also
featured pure protein in all instances.[12] However, the use of
unpurified protein, for example, in the form of crude cell lysate,
is highly desirable for screening of mutants or whole-cell
reactions. We were pleased to find that even crude protein
preparations (as lysed cells or cell-free extract) permitted the
use of spectral unmixing-based reaction monitoring, if appro-
priate background correction is considered and the background
signal remains within a manageable range (see above and the
Supporting Information). In cases where heterogenous reactions
were applied, centrifugation of the quenched alkaline samples
prior to analysis was necessary and successfully reduced back-
ground noise and baseline shifts caused by particles.
Conveniently, spectral shifting of the UV absorption spectra
of the free nucleobases doesn’t always require application of a
strong base. Selected nucleoside-nucleobase pairs feature a
marked spectral shift and stable spectra in a pH region easily
accessible by established buffer systems (e.g., 33–36, Table 1).
This also presents an opportunity to monitor live reactions,
either by applying a continuous assay or discontinuously
monitoring very slow reactions by diluting samples of the
reaction mixture in appropriate buffer (see the Supporting
Information for details).
Some nucleosides precluded application of the original
protocol that involves quenching of reaction samples in
aqueous NaOH. Chlorinated scaffolds 33–36 display remarkably
dynamic UV absorption spectra at pH values above 11 (Fig-
ure S4) and we were unable to obtain reproducible spectral fits
using alkaline quenching. Fortunately, this issue could be
resolved by employing organic solvents like methanol as an
alternative quenching medium and subsequently adjusting the
pH value to 9 for analysis (see the Supporting Information for
details). A similar methodology featuring a different buffer
system succeeded for the trifluorinated pyrimidine 15 (Table 1,
Figure S6).
These examples only present a snapshot of the diverse
applications of spectral unmixing-based reaction monitoring of
transformations between nucleosides and nucleobases that one
may envision. Nonetheless, we are confident that the lessons
learned thus far will translate well to other scenarios, reaction
systems, enzymes and applications where similar issues might
be encountered.
Conclusion
Spectral unmixing presents a powerful tool for the efficient
reaction monitoring of nucleobase cleavage reactions, with
nucleoside phosphorolysis representing a highly relevant exam-
ple. Spectral unmixing of UV absorption spectra conveniently
allows for increased sample throughput compared to other
methods and doesn’t require expensive equipment or reagents.
We have employed this method extensively and demonstrated
its precision, versatility, robustness and ease of handling. This
report extends the range of established substrates and
discusses common problems and notable modifications to the
original protocol. Reference spectra for all substrates and
nucleobases listed in this article[36] as well as our Python code
used for spectral unmixing[37,38] can be obtained from an
external online repository and we are happy to assist with their
use. While specific scenarios may require evaluation and
troubleshooting on a case-to-case basis, the strategies dis-
cussed herein will facilitate the straightforward and versatile
application of this method.
Experimental Section
All chemicals were purchased from Sigma Aldrich, TCI, Carl Roth,
Carbosynth or BioNukleo GmbH at the highest available quality and
used without prior purification. Solutions of all compounds were
prepared in water deionized to 18.2 MW·cm with a Werner water
purification system. NaOH solutions were prepared with deionized
water. Enzymatic reactions were typically prepared from stock
solutions of substrates and buffer and started via the addition of
enzyme. Various NPs were used, including among others Y01, Y02,
N01 and N02 from BioNukleo GmbH, E. coli uridine and thymidine
phosphorylase and purine NP and Bacillus subtilis pyrimidine NP, as
described previously.[12] UV absorption spectra were recorded on a
BioTek PowerWave HT plate reader, using UV/Vis-transparent 96-
well plates (UV-STAR F-Bottom #655801, Greiner Bio-One). Spectral
processing, unmixing and data generation were performed as
described previously[14] with software freely available online.[37,38] All
data presented in this report and the Supporting Information are
freely available from an external online repository.[36]
Reference spectra for pure compounds were prepared from 2 mM
solutions by 10- to 20-fold dilution in aqueous NaOH. Reactions
with purine or pyrimidine nucleosides were typically performed
with either 1 or 2 mM of UV-active compounds. From the 2 mM
reactions, 20 μL (purines) or 30 μL (pyrimidines) were withdrawn
and quenched in NaOH to give a final volume of 500 μL. From the
1 mM reactions, twice as much sample volume was withdrawn and
treated analogously. Note that exact adherence to these volumes is
not necessary, as normalization to the isosbestic point accounts for
differences in signal intensity. For halogenated nucleosides 33–36,
typically, samples of 20 μL were withdrawn and either diluted in
50 mM Tris/NaOH buffer (pH 9) to a volume of 500 μL or quenched
in an equal volume of MeOH or iPrOH before dilution in 50 mM
Tris/NaOH buffer to give a final volume of 500 μL. Similarly, the
fluorinated pyrimidine 15 was sampled by quenching in iPrOH or
MeOH followed by dilution with 100 mM glycine/NaOH buffer
(pH 10) to a final volume of 500 μL. Subsequently, 200 μL of the
diluted alkaline samples were transferred to wells of a UV/Vis-
transparent 96-well plate to record the UV absorption spectra. All
spectra were recorded from 250–350 nm in steps of 1 nm. For exact
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sampling procedures and example reactions, please see our earlier
reports[12,14] and the Supporting Information.
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